Skip to content
Viagra LabsViagra Labs

Finding medicine records around the world

Use English-language sources across Australia, Singapore, the UK, US, Canada, South Africa, New Zealand and Hong Kong.

Viagra Labs is a global English-language reference. A medicine’s absence from the US FDA database is not a worldwide verdict on that medicine. We use country-specific records alongside ingredient evidence and identifiable company information.

Three different questions

First, identify the active ingredient and its established uses. Next, identify the named product: company, dosage form, strength and any additional ingredients. Finally, check the regulatory and supply context in the relevant country. Evidence for one of those questions does not automatically answer the others.

An established company such as Cipla or Ajanta is a useful identity signal. A company homepage, however, does not identify every product it has made or establish that a particular pack is locally registered. The manufacturer, sponsor, importer and marketing authorization holder may be different organizations.

English-language starting points

The official resources below cover the requested markets. Some provide searchable registrations and others direct readers to product information or the regulator’s services. They are starting points for a local check, not a list of countries where every product in this directory is authorized.

Read the scope of the result

Look for the exact ingredient combination, strength and dosage form. Keep the record identifier, named company role and date with the finding. A matching name alone can conceal a different presentation; a tablet registration does not establish an oral-jelly registration.

The Tadacip profile illustrates an Australian record for an Indian-associated brand. Penegra illustrates a Philippines registration. Imported catalogue claims remain visibly distinct from these documented market records.

Sources

The regulator links above were checked for availability on 3 October 2026. This guide explains how we organize evidence; it does not assert availability, import eligibility or registration for every catalogue product in those countries.